Fulcrum Therapeutics (FULC) Other Non-Current Liabilities (2019 - 2025)
Historic Other Non-Current Liabilities for Fulcrum Therapeutics (FULC) over the last 6 years, with Q3 2025 value amounting to $197000.0.
- Fulcrum Therapeutics' Other Non-Current Liabilities changed 0.0% to $197000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $197000.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $197000.0 for FY2024, which is 0.0% changed from last year.
- Latest data reveals that Fulcrum Therapeutics reported Other Non-Current Liabilities of $197000.0 as of Q3 2025, which was down 0.0% from $197000.0 recorded in Q2 2025.
- Fulcrum Therapeutics' Other Non-Current Liabilities' 5-year high stood at $447000.0 during Q2 2023, with a 5-year trough of $197000.0 in Q2 2022.
- Over the past 4 years, Fulcrum Therapeutics' median Other Non-Current Liabilities value was $197000.0 (recorded in 2022), while the average stood at $223642.9.
- In the last 5 years, Fulcrum Therapeutics' Other Non-Current Liabilities skyrocketed by 12690.36% in 2023 and then plummeted by 5592.84% in 2024.
- Over the past 4 years, Fulcrum Therapeutics' Other Non-Current Liabilities (Quarter) stood at $197000.0 in 2022, then changed by 0.0% to $197000.0 in 2023, then changed by 0.0% to $197000.0 in 2024, then changed by 0.0% to $197000.0 in 2025.
- Its Other Non-Current Liabilities stands at $197000.0 for Q3 2025, versus $197000.0 for Q2 2025 and $197000.0 for Q1 2025.